Citadel Advisors - BELLEROPHON THERAPEUTICS INC ownership

BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 16 filers reported holding BELLEROPHON THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of BELLEROPHON THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$40,000
+8.1%
82,744
+33.2%
0.00%
Q2 2019$37,000
+5.7%
62,143
+14.4%
0.00%
Q1 2019$35,000
+29.6%
54,317
+203.5%
0.00%
Q1 2017$27,000
+80.0%
17,897
-36.4%
0.00%
Q4 2016$15,000
-37.5%
28,120
+63.7%
0.00%
Q3 2016$24,000
+14.3%
17,178
+42.0%
0.00%
Q2 2016$21,00012,0960.00%
Other shareholders
BELLEROPHON THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Puissance Capital Management LP 8,298,755$6,651,0007.59%
NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. 15,138,486$16,953,0001.88%
VHCP Management II, LLC 4,149,378$3,325,0001.43%
VHCP Management III, LLC 2,274,370$1,823,0001.32%
ARCH Venture Management, LLC 965,660$774,0000.77%
A.R.T. Advisors, LLC 30,484$24,0000.00%
Virtu Financial LLC 36,708$29,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 183,000$147,0000.00%
GABLES CAPITAL MANAGEMENT INC. 1,400$1,0000.00%
Renaissance Technologies 1,255,476$1,006,0000.00%
View complete list of BELLEROPHON THERAPEUTICS INC shareholders